16:27 EDT Avidity Biosciences files automatic mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNA:
- Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
- Avidity gets FDA Breakthrough Therapy designation for delpacibart etedesiran
- Amgen upgraded, Peloton downgraded: Wall Street’s top analyst calls
- Avidity Biosciences initiated with a Buy at BofA with multiple catalysts in 2024
- Avidity Biosciences initiated with a Buy at BofA